Cellectis S.A. Quarterly Research And Development Expense in USD from Q2 2019 to Q2 2023

Taxonomy & unit
ifrs-full: USD
Summary
Cellectis S.A. annual/quarterly Research And Development Expense history and growth rate from Q2 2019 to Q2 2023.
  • Cellectis S.A. Research And Development Expense for the quarter ending June 30, 2023 was $22.1M, a 13.6% decline year-over-year.
  • Cellectis S.A. annual Research And Development Expense for 2023 was $87.6M, a 10.1% decline from 2022.
  • Cellectis S.A. annual Research And Development Expense for 2022 was $97.5M, a 17.3% decline from 2021.
  • Cellectis S.A. annual Research And Development Expense for 2021 was $118M, a 52.9% increase from 2020.
Research And Development Expense, Quarterly (USD)
Research And Development Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $22.1M -$3.49M -13.6% Apr 1, 2023 Jun 30, 2023 6-K/A 2023-09-05
Q2 2022 $25.6M -$5.52M -17.7% Apr 1, 2022 Jun 30, 2022 6-K/A 2023-09-05
Q2 2021 $31.1M +$8.29M +36.2% Apr 1, 2021 Jun 30, 2021 6-K/A 2022-08-31
Q2 2020 $22.9M -$2.56M -10.1% Apr 1, 2020 Jun 30, 2020 6-K/A 2021-08-31
Q2 2019 $25.4M Apr 1, 2019 Jun 30, 2019 6-K/A 2020-09-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.